Guidance

Diabetes: develop treatments in the UK

Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

Documents

Details

A summary of the UK’s strengths as a centre for diabetes research, prevention, diagnosis and treatment, including information on:

  • research and development (R&D) expertise
  • supply chain support for product development
  • R&D infrastructure

Updates to this page

Published 15 October 2018

Sign up for emails or print this page